Sector
PharmaceuticalsOpen
₹338.9Prev. Close
₹337.95Turnover(Lac.)
₹709.88Day's High
₹344.5Day's Low
₹335.252 Week's High
₹57152 Week's Low
₹257.9Book Value
₹61.04Face Value
₹2Mkt Cap (₹ Cr.)
3,784.38P/E
36.98EPS
9.15Divi. Yield
1.546 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
25 Jun 2024
12:00 AM
AGM
Announcement Date: 25 Jun, 2024
13 May 2025
12:00 AM
Dividend
Dividend Amount: 4
Record Date: 17 May, 2025
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 22.37 | 22.37 | 22.36 | 22.35 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 558.11 | 502.97 | 457.99 | 413.1 |
Net Worth | 580.48 | 525.34 | 480.35 | 435.45 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 272.79 | 283.47 | 247.35 | |
yoy growth (%) | -3.76 | 14.6 | ||
Raw materials | -99.2 | -96.3 | -88.75 | |
As % of sales | 36.36 | 33.97 | 35.88 | |
Employee costs | -39.31 | -34.23 | -32.6 | -32.48 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 72.07 | 98.42 | 75.85 | |
Depreciation | -9.56 | -9 | -8.81 | -7.81 |
Tax paid | -17.56 | -27.41 | -17.89 | |
Working capital | 37.12 | -10.33 | 26.58 | -6.36 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -3.76 | 14.6 | ||
Op profit growth | -27.86 | 31.19 | ||
EBIT growth | -26.75 | 28.03 | ||
Net profit growth | -23.23 | 22.52 | 61.47 | 3.81 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 636.91 | 623.87 | 540.64 | 529.38 | 501.84 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 636.91 | 623.87 | 540.64 | 529.38 | 501.84 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 33.04 | 36.66 | 25.46 | 6.42 | 8.85 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,679.7 | 94.05 | 4,02,788.36 | 2,000.46 | 0.95 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,876 | 82.52 | 1,82,282.67 | 667 | 0.44 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,508.7 | 25.32 | 1,21,846.76 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,334.1 | 59.26 | 1,12,908.79 | 474 | 0.96 | 2,385 | 224.33 |
Dr Reddys Laboratories Ltd DRREDDY | 1,291.3 | 20.06 | 1,07,932.29 | 1,200.7 | 0.62 | 5,546.3 | 345.76 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Whole-time director
MUKUND MADHUSUDAN KABRA
Chairman (Non-Executive)
VASANT RATHI
Independent Director
Pramod Kasat
Company Sec. & Compli. Officer
Sanjay Basantani
Non-Exec & Non-Independent Dir
Rasika Rathi
Independent Director
Vindokumar Hiralal Jajoo
Non-Exec & Non-Independent Dir
Sunny Sharma
Independent Director
Rajshree Patel
Independent Director
NITIN JAGANNATH DESHMUKH
Independent Director
Vandana Tilak.
Sun Magnetica 5th Floor,
Nr LIC Serivce Road Louiswadi,
Maharashtra - 400604
Tel: 91-22-41703200
Website: http://www.advancedenzymes.com
Email: sanjay@advancedenzymes.com; info@advancedenzymes.c
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
Advanced Enzyme Technologies Limited (AETL) is largest Indian enzyme company that has transformed business globally in the manufacturing and sale of enzymes. Advanced Enzyme Technologies Limited was i...
Read More
Reports by Advanced Enzyme Technologies Ltd
What is the Advanced Enzyme Technologies Ltd share price today?
What is the Market Cap of Advanced Enzyme Technologies Ltd?
What is the PE and PB ratio of Advanced Enzyme Technologies Ltd?
What is the 52 Week High and Low of Advanced Enzyme Technologies Ltd?
What is the CAGR of Advanced Enzyme Technologies Ltd?
What is the shareholding pattern of Advanced Enzyme Technologies Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.